Co-occurrence of cohesin complex and Ras signaling mutations during progression from myelodysplastic syndromes to secondary acute myeloid leukemia

Benzer Materyaller

• Are somatic mutations predictive of response to erythropoiesis stimulating agents in lower risk myelodysplastic syndromes?
  Yazar:: Olivier Kosmider, ve diğerleri
  Baskı/Yayın Bilgisi: (2016-07-01)
• Erythropoiesis-stimulating agents are not associated with increased risk of thrombosis in patients with myelodysplastic syndromes
  Yazar:: Sheila Weiss Smith, ve diğerleri
  Baskı/Yayın Bilgisi: (2012-01-01)
• Iron chelation improves ineffective erythropoiesis and iron overload in myelodysplastic syndrome mice
  Yazar:: Wenbin An, ve diğerleri
  Baskı/Yayın Bilgisi: (2023-12-01)
• Patient and physician characteristics associated with erythropoiesis-stimulating agent use in patients with myelodysplastic syndromes
  Yazar:: Amy J. Davidoff, ve diğerleri
  Baskı/Yayın Bilgisi: (2012-01-01)
• Molecular profiling of pre- and post- 5-azacytidine myelodysplastic syndrome samples identifies predictors of response
  Yazar:: Mónica del Rey González, ve diğerleri
  Baskı/Yayın Bilgisi: (2024-09-01)